☆ 4.8 Review

Progress of PD-1/PD-L1 signaling in immune response to liver transplantation for hepatocellular carcinoma

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Prognostic implication of early posttransplant hypercholesterolemia in liver transplantation for patients with hepatocellular carcinoma

Rong-Li Wei et al.

Summary: This study aimed to evaluate the predictive ability of early posttransplant dyslipidemia on the prognosis of hepatocellular carcinoma (HCC) patients after liver transplantation (LT). Through retrospective analysis of 806 HCC patients from the China Liver Transplant Registry database, it was found that early posttransplant hypercholesterolemia was negatively correlated with the risk of recurrence, and borderline hypercholesterolemia indicated a better prognosis, especially in patients beyond Milan criteria but within Hangzhou criteria.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2023)

Add to Collection

Review Immunology

Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients With Advanced Skin Cancers-Emerging Strategies for Clinical Management

Carla Ferrandiz-Pulido et al.

Summary: The use of ICIs in solid organ transplant recipients with advanced skin cancers is a clinical challenge. While kidney transplant recipients can benefit from ICIs as a first-line treatment, for other transplant recipients the use of ICIs should be carefully considered on a case-by-case basis, weighing the benefits against the risk of allograft rejection.

TRANSPLANTATION (2023)

Add to Collection

Review Gastroenterology & Hepatology

Liver transplantation immunology: Immunosuppression, rejection, and immunomodulation

Aldo J. Montano-Loza et al.

Summary: The outcomes of liver transplantation have improved over the years, but long-term survival rates are still lower than the general population. The liver has unique immunological functions and can modulate the recipient's immune system to promote tolerance. Immunosuppressive drugs should be individualized to control alloreactivity while minimizing toxicities.

JOURNAL OF HEPATOLOGY (2023)

Add to Collection

Review Immunology

Mechanisms of drug resistance to immune checkpoint inhibitors in non-small cell lung cancer

Kexun Zhou et al.

Summary: Immune checkpoint inhibitors (ICIs) have shown great promise in prolonging the survival of patients with advanced non-small cell lung cancer (NSCLC). However, resistance to ICIs remains a challenge, with different mechanisms and tumor microenvironment playing a critical role.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Article Oncology

Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China

Yun-Wei Yan et al.

Summary: This study analyzed the current situation and problems associated with the Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China. The study found that early diagnosis and treatment can be achieved by screening high-risk groups, but real-world compliance is poor.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2023)

Add to Collection

Article Engineering, Multidisciplinary

Gut Microbiota Modulation: A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation

Ze Xiang et al.

Engineering (2023)

Add to Collection

Review Oncology

The Liver-Immunity Nexus and Cancer Immunotherapy

James C. Lee et al.

Summary: Liver metastases have a significant impact on the effectiveness of immune checkpoint inhibitors in patients with solid-tumor malignancies. Multiple clinical and translational studies have shown that liver metastasis leads to systemic immune suppression through the generation of suppressive macrophages and activation of regulatory T-cells. Various interventions, such as radiation therapy and combination checkpoint blockade, have been reported to address liver immune suppression.

CLINICAL CANCER RESEARCH (2022)

Add to Collection

Review Oncology

Resident Immune Cells of the Liver in the Tumor Microenvironment

Yunjie Lu et al.

Summary: The liver plays a crucial role in maintaining a balance between protection and immunotolerance, and the deregulation of the immunological network in hepatocellular carcinoma (HCC) is a hallmark of its pathogenesis. The immune response in the liver involves various immune cells and is modulated by continuous exposure to toxic molecules and microorganisms. Understanding the roles of different resident immune cell subsets and their interaction in HCC pathogenesis may lead to the identification of new biomarkers and therapy options.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Review Chemistry, Analytical

Dostarlimab as a Miracle Drug: Rising Hope against Cancer Treatment

Vanshikha Singh et al.

Summary: Immunotherapy, especially the use of anti-PD-1 monoclonal antibody Dostarlimab, has shown promising results in various cancer treatments, with complete cure observed in colorectal cancer patients. This review emphasizes the mechanism of action of immunotherapy and discusses the ongoing clinical trials and combination therapies involving Dostarlimab to provide insights for future clinicians and researchers.

BIOSENSORS-BASEL (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Impact of nitric oxide in liver cancer microenvironment

Sandra Dios-Barbeito et al.

Summary: The regulation of nitric oxide generation in the tumor microenvironment plays a crucial role in hepatocellular carcinoma. The increased expression of NOS2 is associated with poor prognosis, yet the functional relevance seems to be influenced by different etiologies.

NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2022)

Add to Collection

Review Microbiology

Advances in multi-omics research on viral hepatitis

Ze Xiang et al.

Summary: Viral hepatitis is a significant global public health problem that affects millions of people and has high morbidity and mortality. Multi-omics analysis has been widely used in studying the origin, diagnosis, and treatment targets of viral hepatitis.

FRONTIERS IN MICROBIOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

PD-L1-Mediated Immunosuppression in Hepatocellular Carcinoma: Relationship with Macrophages Infiltration and Inflammatory Response Activity

Shuang Guo et al.

Summary: Immune dysfunction and pro-oncogenic inflammation play critical roles in malignant progression and non-response to immunotherapy for hepatocellular carcinoma (HCC). In this study, the intercommunication between PD-L1 and the immunosuppressive tumor microenvironment (TME) and inflammatory response activity in HCC was investigated. Additionally, potential therapeutic drugs were predicted to improve the current therapeutic strategy for specific HCC patients.

BIOMOLECULES (2022)

Add to Collection

Article Medicine, General & Internal

Predicting survival for hepatic arterial infusion chemotherapy of unresectable colorectal liver metastases: Radiomics analysis of pretreatment computed tomography

Peng Liu et al.

Summary: This study demonstrates that a radiomics approach based on pretreatment CT texture analysis has the ability to predict the outcome of HAIC in patients with advanced unresectable colorectal cancer with a high degree of accuracy and feasibility.

JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE (2022)

Add to Collection

Article Medicine, General & Internal

Dysregulation of miR-144-5p/RNF187 axis contributes to the progression of colorectal cancer

Zhuo Gao et al.

Summary: This study reveals the upregulation of RNF187 in colorectal cancer (CRC) and its association with poor prognosis. Inhibition of RNF187 expression suppresses the proliferation, migration, and invasion while promoting apoptosis of CRC cells. miR-144-5p is identified as a direct target of RNF187, and its downregulation in CRC tissues is negatively correlated with RNF187 expression. Restoration of miR-144-5p significantly inhibits CRC cell progression, which can be abolished by overexpression of RNF187.

JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE (2022)

Add to Collection

Article Gastroenterology & Hepatology

Gut microbiota dysbiosis in Chinese children with type 1 diabetes mellitus: An observational study

Xia Liu et al.

Summary: The study revealed significant increase in bacterial diversity and changes in microbial composition in gut microbiota of children with T1DM. Certain taxa were found to be positively correlated with fasting blood glucose while others were negatively correlated, suggesting their potential use as diagnostic biomarkers. Additionally, functional changes in the gut microbiota were associated with altered metabolic activities, possibly playing crucial roles in the development of T1DM.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Review Immunology

Downstaging treatment for patients with hepatocelluar carcinoma before transplantation

Guangjiang Jiang et al.

Summary: Liver transplantation is a radical method for treating unresectable liver cancer, with favorable prognosis for eligible patients but less satisfactory outcomes for those exceeding criteria. Downstaging treatment shows promise in reducing tumor burden to within transplant criteria, although issues such as inclusion criteria, treatment method choice, and endpoint of downstaging need further discussion.

TRANSPLANTATION REVIEWS (2021)

Add to Collection

Review Infectious Diseases

Extrahepatic manifestations related to hepatitis E virus infection and their triggering mechanisms

Jian Wu et al.

Summary: Hepatitis E virus (HEV) infection has various extrahepatic manifestations affecting multiple organ systems, indicating it should be considered as a systemic disease. Different genotypes of HEV can induce different extrahepatic manifestations, and the severity of these diseases does not necessarily correlate with the severity of HEV infection. Antiviral therapy may alleviate or improve the extrahepatic manifestations related to HEV infection.

JOURNAL OF INFECTION (2021)

Add to Collection

Article Surgery

Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient?

Mina F. Nordness et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Add to Collection

Article Immunology

Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation

Federica Invernizzi et al.

TRANSPLANTATION (2020)

Add to Collection

Review Gastroenterology & Hepatology

Gastrointestinal adverse events associated with immune checkpoint inhibitor therapy

Eva Rajha et al.

GASTROENTEROLOGY REPORT (2020)

Add to Collection

Review Oncology

Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

J. Haanen et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection

Article Cell Biology

The Protective Effects and the Involved Mechanisms of Tanshinone IIA on Sepsis-Induced Brain Damage in Mice

Cun-quan Xiong et al.

INFLAMMATION (2019)

Add to Collection

Article Oncology

An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade

Lynda Vuong et al.

CANCER RESEARCH (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape

Xianjie Jiang et al.

MOLECULAR CANCER (2019)

Add to Collection

Review Medicine, Research & Experimental

The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation

Chenxia Hu et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2019)

Add to Collection

Article Immunology

Generation and persistence of human tissue-resident memory T cells in lung transplantation

Mark E. Snyder et al.

SCIENCE IMMUNOLOGY (2019)

Add to Collection

Letter Oncology

Graft rejection after immune checkpoint inhibitor therapy in solid organ transplant recipients

Tor Magnus Smedman et al.

ACTA ONCOLOGICA (2018)

Add to Collection

Article Oncology

CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naive Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment

Jarem Edwards et al.

CLINICAL CANCER RESEARCH (2018)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Pembrolizumab for metastatic hepatocellular carcinoma following live donor liver transplantation: The silver bullet?

Ashwin Rammohan et al.

HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Graft-infiltrating PD-L1hi cross-dressed dendritic cells regulate antidonor T cell responses in mouse liver transplant tolerance

Yoshihiro Ono et al.

HEPATOLOGY (2018)

Add to Collection

Review Immunology

The function and dysfunction of memory CD8+ T cells in tumor immunity

James L. Reading et al.

IMMUNOLOGICAL REVIEWS (2018)

Add to Collection

Review Gastroenterology & Hepatology

Use of checkpoint inhibitors in liver transplant recipients

Stefan Munker et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)

Add to Collection

Article Oncology

Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients

Priyanka B. Subrahmanyam et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

Add to Collection

Article Cell Biology

PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes

Moufida Ben Nasr et al.

SCIENCE TRANSLATIONAL MEDICINE (2017)

Add to Collection

Review Pharmacology & Pharmacy

PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome

Hashem O. Alsaab et al.

FRONTIERS IN PHARMACOLOGY (2017)

Add to Collection

Article Surgery

OPTN/SRTR 2015 Annual Data Report: Liver

W. R. Kim et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2017)

Add to Collection

Letter Gastroenterology & Hepatology

Preserved Liver Transplant After PD-1 Pathway Inhibitor for Hepatocellular Carcinoma

Andreas Varkaris et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Counter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction

Xiao-Lei Shi et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Article Immunology

Periodontal Pathogens Invade Gingiva and Aortic Adventitia and Elicit Inflammasome Activation in αvβ6 Integrin-Deficient Mice

Irina M. Velsko et al.

INFECTION AND IMMUNITY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study

Joong-Won Park et al.

LIVER INTERNATIONAL (2015)

Add to Collection

Review Medicine, General & Internal

Recent advances in the field of anti-cancer immunotherapy

Henrique Neves et al.

BBA CLINICAL (2015)

Add to Collection

Review Oncology

PD-1 as an Immune Modulatory Receptor

Sheng Yao et al.

CANCER JOURNAL (2014)

Add to Collection

Article Immunology

CD152 and PD-1 Down-Regulation on CD8 T Cells Is Associated With Human Acute Liver Allograft Rejection

Z. Liu et al.

TRANSPLANTATION PROCEEDINGS (2014)

Add to Collection

Article Oncology

Increased PD-1 expression on CD4+and CD8+T cells is involved in immune evasion in gastric cancer

Hiroaki Saito et al.

JOURNAL OF SURGICAL ONCOLOGY (2013)

Add to Collection

Article Gastroenterology & Hepatology

Hepatic B7 Homolog 1 Expression Is Essential for Controlling Cold Ischemia/Reperfusion Injury After Mouse Liver Transplantation

Shinya Ueki et al.

HEPATOLOGY (2011)

Add to Collection

Article Surgery

PD-1/B7-H1 Interaction Contribute to the Spontaneous Acceptance of Mouse Liver Allograft

M. Morita et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2010)

Add to Collection

Article Oncology

Improved Results of a Surgical Resection for the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation

Akinobu Taketomi et al.

ANNALS OF SURGICAL ONCOLOGY (2010)

Add to Collection

Review Immunology

Immune tolerance: What is unique about the liver

Gisa Tiegs et al.

JOURNAL OF AUTOIMMUNITY (2010)

Add to Collection

Article Cell & Tissue Engineering

Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens

Qijin Xu et al.

STEM CELLS (2009)

Add to Collection

Review Immunology

Multiple roles for CD4(+) T cells in anti-tumor immune responses

Richard Kennedy et al.

IMMUNOLOGICAL REVIEWS (2008)

Add to Collection

Review Immunology

Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways

Brian T. Fife et al.

IMMUNOLOGICAL REVIEWS (2008)

Add to Collection

Article Immunology

PD-1 - PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating T cells during murine GVHD across minor histocompatibility antigen barriers

Karin Schilbach et al.

TRANSPLANTATION (2007)

Add to Collection

Article Immunology

The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA

M Croft

TRENDS IN IMMUNOLOGY (2005)

Add to Collection

Review Rheumatology

Apoptosis: Programmed cell death at a molecular level

DR Schultz et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2003)

Add to Collection

Article Immunology

Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation

LL Carter et al.

IMMUNOLOGIC RESEARCH (2003)

Add to Collection

Review Pharmacology & Pharmacy

T-helper type 2 cell-directed therapy for asthma

L Cohn et al.

PHARMACOLOGY & THERAPEUTICS (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.